Tizanidine Tablet
Product Images NDC 84386-023

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 84386-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Tizanidine Fig1)

A line graph showing plasma tizanidine concentration (ng/mL) versus hours from dosing. The graph compares four conditions: 4 mg tizanidine tablets and capsules taken with and without food, depicting changes in drug concentration over 24 hours after dosing.*

FDA Label Image

Figure2 (Tizanidine Fig2)

Line graph showing improvement in Ashworth Score over time (hours post-dose) for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The vertical axis represents improvement in Ashworth Score, and the horizontal axis represents hours post-dose from 0 to 6. Data points include error bars indicating variability.*

FDA Label Image

Figure3 (Tizanidine Fig3)

A line chart comparing improvement in Ashworth Score over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and End point (Last Observation Carried Forward). The chart shows data for tizanidine (mean dose 28.8 mg) and placebo, with tizanidine demonstrating greater improvement scores at each point with error bars indicating variability.*

FDA Label Image

Package Label-principal Display Panel (2 mg (150 Container Label))

Label for Tizanidine Tablets, USP 2 mg by Aurobindo Pharma Limited featuring a 150 tablet count. The label includes dosage and storage instructions, manufacturer information, and a prominent display of the strength 2 mg in a yellow oval. It states the medication is prescription-only and lists distributor and manufacturer addresses along with regulatory details and barcode.*

FDA Label Image

Package Label-principal Display Panel (4 mg (150 Container Label))

Label for Tizanidine Tablets, USP 4 mg oral tablets by Aurobindo Pharma Limited. The label includes dosage strength, quantity (150 tablets), storage instructions, manufacturer and distributor information, and a barcode. It states the tablets contain 4 mg tizanidine equivalent to 4.576 mg tizanidine hydrochloride. The label also contains regulatory and packaging details.*

FDA Label Image

Chemical Structure (Tizanidine Str)

Chemical structure of Tizanidine hydrochloride, showing its molecular framework with chlorine and nitrogen-sulfur heterocyclic rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.